全球首款口服六价重配轮状病毒减毒活疫苗（Vero细胞）在武汉亮相

Group 1 - The core point of the article is the introduction of the world's first oral six-valent reconfigured rotavirus attenuated live vaccine developed by the Wuhan Institute of Biological Products, which is set to be available for administration by the end of December this year [1] Group 2 - The vaccine is based on Vero cell technology, indicating a significant advancement in vaccine development within the industry [1] - The launch of this vaccine represents a milestone in the fight against rotavirus, which is a leading cause of severe diarrhea in children [1] - The rapid timeline for availability suggests a proactive approach by the company to address public health needs [1]